ISRCTN87369174已完成不适用
Randomised controlled trial of Levosimendan vs Enoximone in Cardiogenic Shock
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)0 个研究点目标入组 12 人开始时间: 2004年9月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients over 18 years of age.
- •2. All patients that are suspected of having cardiogenic shock during their admission to the Critical Care Unit will be identified.
排除标准
- •Not provided at time of registration
研究者
相似试验
招募中
4 期
Comparison between Levosimendan with Dobutamine in acute heart failureCTRI/2018/08/015293Department of PharmacologyIPGMERKOLKATA
进行中（未招募）
1 期
Randomized phase II Trial comparing Lenalidomide with lowdose dexamethasone versus Lenalidomide inSecond Line Multiple Myeloma (MM)Multiple myelomaMedDRA version: 16.1Level: LLTClassification code 10028231Term: Multiple myeloma in remissionSystem Organ Class: 100000004864MedDRA version: 16.1Level: LLTClassification code 10028233Term: Multiple myeloma without mention of remissionSystem Organ Class: 100000004864MedDRA version: 16.1Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2010-021857-38-SEKarolinska University Hospital60
进行中（未招募）
1 期
A study to test whether lasmiditan is safe and effective in the treatment of migraine with or without aura over four attacksMigraineEUCTR2018-001661-17-ESilly S.A.1,471
已完成
3 期
Randomized Controlled Trial of Lasmiditan Over Four Migraine AttacksmigraineHeadache10019231NL-OMON48626Eli Lilly37
进行中（未招募）
1 期
A Study of Lasmiditan (LY573144) Over Four Migraine AttacksMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraineEUCTR2018-001661-17-DKEli Lilly and Company1,471